Literature DB >> 22206689

Triacylglycerols and body fat mass are possible independent predictors of C3 in apparently healthy young Brazilian adults.

Ana Carolina Pinheiro Volp1, Kiriaque Barra Ferreira Barbosa, Josefina Bressan.   

Abstract

OBJECTIVE: To evaluate the association between serum concentrations of complement factor-3 (C3) with anthropometric, biochemical, and lifestyle features in healthy young adults.
METHODS: From 157 young healthy adults 18 to 35 y old, anthropometric measurements and body composition, systolic and diastolic blood pressures, and lifestyle data were collected and analyzed. Blood samples were collected after a 12-h fast for the determination of glucose, triacylglycerols, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, insulin, C3, ceruloplasmin, and uric acid.
RESULTS: Complement factor-3 correlated directly with body mass index (r = 0.23417, P = 0.0032), body fat mass (bioelectrical impedance analysis; r = 0.33407, P < 0.0001), percentage of body fat (bioelectrical impedance analysis; r = 0.26873, P = 0.0007), waist circumference (r = 0.21266, P = 0.0075), insulin (r = 0.26152, P = 0.0009), homeostasis model assessment of insulin resistance (r = 0.24831, P = 0.0017), total cholesterol (r = 0.23335, P = 0.0033), triacylglycerols (r = 0.38435, P < 0.0001), and other outcome measurements. In the multiple linear regression analysis, triacylglycerols (r(2) = 0.1379, P < 0.0001) and body fat mass (bioelectrical impedance analysis; r(2) = 0.0621, P = 0.0010) were independently associated with the C3 concentration after adjusting for age, gender, smoking status, and physical activity.
CONCLUSION: Complement factor-3 seems to be related to several anthropometric and biochemical measurements in healthy young adults. These results demonstrate an independent role of triacylglycerols, a component of the metabolic syndrome, and body fat mass as possible predictors of C3 concentrations. Thus, C3 can be used as an early marker for metabolic syndrome manifestations.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22206689     DOI: 10.1016/j.nut.2011.08.014

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  4 in total

1.  Hypertriglyceridemia accompanied by increased serum complement component 3 and proteinuria in non-nephrotic chronic kidney disease.

Authors:  Kentaro Kohagura; Masako Kochi; Tsuyoshi Miyagi; Takanori Kinjyo; Yuichi Maehara; Kojiro Kinjyo; Kazufumi Nagahama; Atsushi Sakima; Kunitoshi Iseki; Yusuke Ohya
Journal:  Clin Exp Nephrol       Date:  2013-06-12       Impact factor: 2.801

2.  Clinical analysis of selected complement-derived molecules in human adipose tissue.

Authors:  Wojciech Błogowski; Marta Budkowska; Daria Sałata; Karol Serwin; Barbara Dołęgowska; Marek Łokaj; Piotr Prowans; Teresa Starzyńska
Journal:  J Transl Med       Date:  2013-01-09       Impact factor: 5.531

Review 3.  Dyslipidemia in obesity: mechanisms and potential targets.

Authors:  Boudewijn Klop; Jan Willem F Elte; Manuel Castro Cabezas
Journal:  Nutrients       Date:  2013-04-12       Impact factor: 5.717

4.  Downregulation of complement C3 and C3aR expression in subcutaneous adipose tissue in obese women.

Authors:  Abhishek Gupta; Reza Rezvani; Marc Lapointe; Pegah Poursharifi; Picard Marceau; Sunita Tiwari; Andre Tchernof; Katherine Cianflone
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.